Clinical Development of BRAF plus MEK Inhibitor Combinations von Subbiah, Vivek, Baik, Christina, Kirkwood, John M

Volltext

Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells von Sharma, Priyanka, Diergaarde, Brenda, Ferrone, Soldano, Kirkwood, John M., Whiteside, Theresa L.

Volltext

Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients von Davar, Diwakar, Dzutsev, Amiran K, McCulloch, John A, Rodrigues, Richard R, Chauvin, Joe-Marc, Morrison, Robert M, Deblasio, Richelle N, Menna, Carmine, Ding, Quanquan, Pagliano, Ornella, Zidi, Bochra, Zhang, Shuowen, Badger, Jonathan H, Vetizou, Marie, Cole, Alicia M, Fernandes, Miriam R, Prescott, Stephanie, Costa, Raquel G F, Balaji, Ascharya K, Morgun, Andrey, Vujkovic-Cvijin, Ivan, Wang, Hong, Borhani, Amir A, Schwartz, Marc B, Dubner, Howard M, Ernst, Scarlett J, Rose, Amy, Najjar, Yana G, Belkaid, Yasmine, Kirkwood, John M, Trinchieri, Giorgio, Zarour, Hassane M

Volltext

Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual von Gershenwald, Jeffrey E., Scolyer, Richard A., Hess, Kenneth R., Sondak, Vernon K., Long, Georgina V., Ross, Merrick I., Lazar, Alexander J., Faries, Mark B., Kirkwood, John M., McArthur, Grant A., Haydu, Lauren E., Eggermont, Alexander M. M., Flaherty, Keith T., Balch, Charles M., Thompson, John F., Gershenwald, Jeffrey E., Scolyer, Richard A., Atkins, Michael B., Balch, Charles M., Barnhill, Raymond L., Bilimoria, Karl Y., Buzaid, Antonio C., Byrd, David R., Cochran, Alistair J., Eggermont, Alexander M. M., Elder, David E., Faries, Mark B., Flaherty, Keith T., Garbe, Claus, Gardner, Julie M., Gimotty, Phyllis A., Halpern, Allan C., Haydu, Lauren E., Hess, Kenneth R., Johnson, Timothy M., Kirkwood, John M., Lazar, Alexander J., Lee, Anne W. M., Long, Georgina V., McArthur, Grant A., Mihm Jr, Martin C., Prieto, Victor G., Ross, Merrick I., Sober, Arthur J., Sondak, Vernon K., Thompson, John F., Wong, Sandra L., Delman, Keith A., Santinami, Mario, Maurichi, Andrea, Nagore, Eduardo, Faries, Mark B., Thompson, John F., Scolyer, Richard A., McArthur, Grant A., Gyorki, David E., Henderson, Michael, Stratigos, Alexander J., Gogas, Helen, Gershenwald, Jeffrey E., Haydu, Lauren E., Rossi, Carlo Riccardo, Sommariva, Antonio

Volltext

Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG) von Anker, Christopher J., MD, Grossmann, Kenneth F., MD, PhD, Atkins, Michael B., MD, Suneja, Gita, MD, Tarhini, Ahmad A., MD, PhD, Kirkwood, John M., MD

Volltext

Immunotherapy of cancer in 2012 von Kirkwood, John M., Butterfield, Lisa H., Tarhini, Ahmad A., Zarour, Hassane, Kalinski, Pawel, Ferrone, Soldano

Volltext

Systemic Therapy for Melanoma: ASCO Guideline von Seth, Rahul, Messersmith, Hans, Kaur, Varinder, Kirkwood, John M, Kudchadkar, Ragini, McQuade, Jennifer Leigh, Provenzano, Anthony, Swami, Umang, Weber, Jeffrey, Alluri, Krishna C, Agarwala, Sanjiv, Ascierto, Paolo A, Atkins, Michael B, Davis, Nancy, Ernstoff, Marc S, Faries, Mark B, Gold, Jason S, Guild, Samantha, Gyorki, David E, Khushalani, Nikhil I, Meyers, Michael O, Robert, Caroline, Santinami, Mario, Sehdev, Amikar, Sondak, Vernon K, Spurrier, Gilliosa, Tsai, Katy K, van Akkooi, Alexander, Funchain, Pauline

Volltext

Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma von Sharma, Priyanka, Ludwig, Sonja, Muller, Laurent, Hong, Chang Sook, Kirkwood, John M, Ferrone, Soldano, Whiteside, Theresa L.

Volltext

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects von Garbe, Claus, Eigentler, Thomas K., Keilholz, Ulrich, Hauschild, Axel, Kirkwood, John M.

Volltext

The role of BRAF V600 mutation in melanoma von Ascierto, Paolo A, Kirkwood, John M, Grob, Jean-Jacques, Simeone, Ester, Grimaldi, Antonio M, Maio, Michele, Palmieri, Giuseppe, Testori, Alessandro, Marincola, Francesco M, Mozzillo, Nicola

Volltext

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma von Sarnaik, Amod A, Hamid, Omid, Khushalani, Nikhil I, Lewis, Karl D, Medina, Theresa, Kluger, Harriet M, Thomas, Sajeve S, Domingo-Musibay, Evidio, Pavlick, Anna C, Whitman, Eric D, Martin-Algarra, Salvador, Corrie, Pippa, Curti, Brendan D, Oláh, Judit, Lutzky, Jose, Weber, Jeffrey S, Larkin, James M G, Shi, Wen, Takamura, Toshimi, Jagasia, Madan, Qin, Harry, Wu, Xiao, Chartier, Cecile, Graf Finckenstein, Friedrich, Fardis, Maria, Kirkwood, John M, Chesney, Jason A

Volltext

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial von Long, Georgina V, Dr, Trefzer, Uwe, MD, Davies, Michael A, MD, Kefford, Richard F, Prof, Ascierto, Paolo A, MD, Chapman, Paul B, MD, Puzanov, Igor, MD, Hauschild, Axel, MD, Robert, Caroline, PhD, Algazi, Alain, MD, Mortier, Laurent, Prof, Tawbi, Hussein, PhD, Wilhelm, Tabea, MD, Zimmer, Lisa, MD, Switzky, Julie, MSN, Swann, Suzanne, PhD, Martin, Anne-Marie, PhD, Guckert, Mary, MSN, Goodman, Vicki, MD, Streit, Michael, MD, Kirkwood, John M, Prof, Schadendorf, Dirk, Prof

Volltext

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Up... von Wong, Sandra L, Faries, Mark B, Kennedy, Erin B, Agarwala, Sanjiv S, Akhurst, Timothy J, Ariyan, Charlotte, Balch, Charles M, Berman, Barry S, Cochran, Alistair, Delman, Keith A, Gorman, Mark, Kirkwood, John M, Moncrieff, Marc D, Zager, Jonathan S, Lyman, Gary H

Volltext

Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab von Tarhini, Ahmad A, Edington, Howard, Butterfield, Lisa H, Lin, Yan, Shuai, Yongli, Tawbi, Hussein, Sander, Cindy, Yin, Yan, Holtzman, Matthew, Johnson, Jonas, Rao, Uma N M, Kirkwood, John M

Volltext

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma von RIBAS, Antoni, KEFFORD, Richard, LORIGAN, Paul, KENDRA, Kari L, MAIO, Michele, TREFZER, Uwe, SMYLIE, Michael, MCARTHUR, Grant A, DRENO, Brigitte, NATHAN, Paul D, MACKIEWICZ, Jacek, KIRKWOOD, John M, MARSHALL, Margaret A, GOMEZ-NAVARRO, Jesus, BO HUANG, PAVLOV, Dmitri, HAUSCHILD, Axel, PUNT, Cornelis J. A, HAANEN, John B, MARMOL, Maribel, GARBE, Claus, GOGAS, Helen, SCHACHTER, Jacob, LINETTE, Gerald

Volltext

Final Version of 2009 AJCC Melanoma Staging and Classification von Balch, Charles M, Gershenwald, Jeffrey E, Soong, Seng-Jaw, Thompson, John F, Atkins, Michael B, Byrd, David R, Buzaid, Antonio C, Cochran, Alistair J, Coit, Daniel G, Ding, Shouluan, Eggermont, Alexander M, Flaherty, Keith T, Gimotty, Phyllis A, Kirkwood, John M, McMasters, Kelly M, Mihm, Jr, Martin C, Morton, Donald L, Ross, Merrick I, Sober, Arthur J, Sondak, Vernon K

Volltext

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease von Boyiadzis, Michael M, Kirkwood, John M, Marshall, John L, Pritchard, Colin C, Azad, Nilofer S, Gulley, James L

Volltext

Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma von FLAHERTY, Keith T, LEE, Sandra J, FENGMIN ZHAO, SCHUCHTER, Lynn M, FLAHERTY, Lawrence, KEFFORD, Richard, ATKINS, Michael B, LEMING, Philip, KIRKWOOD, John M

Volltext

Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma von Rohatgi, Anjali, Kirkwood, John M

Volltext

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma von Tarhini, Ahmad A, Zahoor, Haris, Lin, Yan, Malhotra, Usha, Sander, Cindy, Butterfield, Lisa H, Kirkwood, John M

Volltext